Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of the Prevalence of Endogenous Hypercortisolism in Patients With Resistant Hypertension in the United States of America (MOMENTUM)

NCT06829537 is registered in ClinicalTrials.gov with Corcept Therapeutics as lead sponsor.

NCT NCT06829537
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06829537 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of the Prevalence of Endogenous Hypercortisolism in Patients With Resistant Hypertension in the United States of America (MOMENTUM)
Lead sponsor
Corcept Therapeutics
Phase
Observational
Overall status
Completed
Start date
March 28, 2025
Completion date
January 23, 2026
Enrollment
1,143 (actual)
Sites
50

Conditions

As the registry lists them; a condition with its own page is linked.

hypercortisolism, resistant hypertension